Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Symptom interference negatively affects quality of life in women with ovarian cancer.

Prolonged use of topical corticosteroids can cause excessive hair growth.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Hairline-lowering surgery effectively reduces a high hairline with immediate, noticeable results.

The marine complex supplement significantly improved hair growth in men with thinning hair without adverse effects.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Cleanroom workers in a battery factory have worse skin and eye conditions due to the very dry environment.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Improved care and timely diagnosis are needed for women with PCOD and PCOS, and CystaCare can help.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hair loss causes stress and affects mental health; treatment and support needed.

New methods have greatly improved our understanding of stem cell behavior and roles in the body.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Finasteride effectively treats male hair loss, improving growth and density.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Healthcare organizations must seriously focus on strategic decision-making to succeed in a complex market.

Wig users with alopecia do a lot of emotional and practical work to make their wigs look natural and manage how others see them.

Traditional Chinese medications can cause skin reactions, and better testing and reporting are needed to identify allergens.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.